Portal de Periódicos da CAPES

Revisão Acesso aberto Produção Nacional Revisado por pares

BIBTEX RIS

Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions

2021; Multidisciplinary Digital Publishing Institute; Volume: 22; Issue: 5 Linguagem: Inglês

10.3390/ijms22052639

1661-6596

Ana Rita de Oliveira dos Santos, Bárbara de Oliveira Zanuso, Vitor Fernando Bordin Miola, Sandra Maria Barbalho, Patrícia C. Santos Bueno, Uri Adrian Prync Flato, Cláudia Rucco Penteado Detregiachi, Daniela Vieira Buchaim, Rogério Leone Buchaim, Ricardo José Tofano, Claudemir Gregório Mendes, Viviane Alessandra Capelluppi Tofano, Jesselina Francisco dos Santos Haber,

Adipose Tissue and Metabolism

Adipose, skeletal, and hepatic muscle tissues are the main endocrine organs that produce adipokines, myokines, and hepatokines. These biomarkers can be harmful or beneficial to an organism and still perform crosstalk, acting through the endocrine, paracrine, and autocrine pathways. This study aims to review the crosstalk between adipokines, myokines, and hepatokines. Far beyond understanding the actions of each biomarker alone, it is important to underline that these cytokines act together in the body, resulting in a complex network of actions in different tissues, which may have beneficial or non-beneficial effects on the genesis of various physiological disorders and their respective outcomes, such as type 2 diabetes mellitus (DM2), obesity, metabolic syndrome, and cardiovascular diseases (CVD). Overweight individuals secrete more pro-inflammatory adipokines than those of a healthy weight, leading to an impaired immune response and greater susceptibility to inflammatory and infectious diseases. Myostatin is elevated in pro-inflammatory environments, sharing space with pro-inflammatory organokines, such as tumor necrosis factor-alpha (TNF-α), interleukin-1 (IL-1), resistin, and chemerin. Fibroblast growth factor FGF21 acts as a beta-oxidation regulator and decreases lipogenesis in the liver. The crosstalk mentioned above can interfere with homeostatic disorders and can play a role as a potential therapeutic target that can assist in the methods of diagnosing metabolic syndrome and CVD.